Stockscreener 앱 받기
1.60
1.84%
-0.03
시간 외 거래:
1.62
0.02
+1.25%
전일 마감가:
$1.63
열려 있는:
$1.56
하루 거래량:
262.55K
Relative Volume:
0.99
시가총액:
$85.94M
수익:
-
순이익/손실:
$-31.39M
주가수익비율:
-1.9048
EPS:
-0.84
순현금흐름:
$-18.45M
1주 성능:
-7.51%
1개월 성능:
-3.03%
6개월 성능:
+50.94%
1년 성능:
+4.58%
1일 변동 폭
$1.555
$1.62
1주일 범위
$1.555
$1.735
52주 변동 폭
$0.7203
$2.45
Quince Therapeutics Inc Stock (QNCX) Company Profile
명칭
Quince Therapeutics Inc
전화
415-910-5717
주소
611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO
QNCX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QNCX
Quince Therapeutics Inc
|
1.60 | 87.55M | 0 | -31.39M | -18.45M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Quince Therapeutics Inc Stock (QNCX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-05 | 개시 | Citizens JMP | Mkt Outperform |
| 2025-03-24 | 개시 | Oppenheimer | Outperform |
Quince Therapeutics Inc 주식(QNCX)의 최신 뉴스
Why retail investors favor Quince Therapeutics Inc. stockShare Buyback & Consistent Income Trade Recommendations - newser.com
How interest rate cuts could boost Quince Therapeutics Inc. stock - newser.com
Statistical indicators supporting Quince Therapeutics Inc.’s strengthIndex Update & Safe Swing Trade Setup Alerts - newser.com
Is Quince Therapeutics Inc. stock cheap compared to fundamentals2025 Price Momentum & AI Enhanced Trading Signals - newser.com
Sentiment analysis tools applied to Quince Therapeutics Inc.Quarterly Earnings Summary & Daily Oversold Bounce Ideas - newser.com
Market reaction to Quince Therapeutics Inc.’s recent newsGold Moves & Technical Pattern Recognition Alerts - newser.com
Short Interest in Quince Therapeutics, Inc. (NASDAQ:QNCX) Rises By 48.1% - MarketBeat
Is Quince Therapeutics Inc. stock positioned for digital transformationQuarterly Portfolio Report & Safe Capital Growth Tips - newser.com
Is Quince Therapeutics Inc. stock oversold or undervaluedWeekly Gains Report & Verified Swing Trading Watchlist - newser.com
Will earnings trigger a reversal in Quince Therapeutics Inc.2025 Biggest Moves & Verified Entry Point Signals - newser.com
Is Quince Therapeutics Inc. stock a buy in volatile marketsPortfolio Return Report & Verified High Yield Trade Plans - newser.com
What indicators show strength in Quince Therapeutics Inc.Stop Loss & Proven Capital Preservation Tips - newser.com
How Quince Therapeutics Inc. stock performs in rising dollar environmentJuly 2025 Macro Moves & Community Verified Swing Trade Signals - newser.com
How to forecast Quince Therapeutics Inc. trends using time series2025 Buyback Activity & Free Long-Term Investment Growth Plans - newser.com
Is Quince Therapeutics Inc. stock a good choice for value investorsPortfolio Risk Summary & Stock Market Timing Techniques - newser.com
Quince Therapeutics Inc. stock volume spike explainedPortfolio Profit Report & Smart Allocation Stock Tips - newser.com
Will Quince Therapeutics Inc. stock recover faster than peers2025 Market WrapUp & Community Trade Idea Sharing - newser.com
Can Quince Therapeutics Inc. stock double in next 5 yearsIPO Watch & Entry Point Strategy Guides - newser.com
What hedge fund activity signals for Quince Therapeutics Inc. stockQuarterly Growth Report & Free Reliable Trade Execution Plans - newser.com
How analysts rate Quince Therapeutics Inc. stock todayJuly 2025 PreEarnings & Precise Swing Trade Entry Alerts - newser.com
Combining machine learning predictions for Quince Therapeutics Inc.Earnings Recap Report & Fast Gaining Stock Reports - newser.com
Is Quince Therapeutics Inc. showing signs of accumulationPrice Action & Safe Investment Capital Preservation Plans - newser.com
Is Quince Therapeutics Inc. stock ready for a breakoutIndex Update & Proven Capital Preservation Methods - newser.com
Quince Therapeutics Inc (QNCX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):